Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2009
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1339318B1 Device for collecting, handling and processing mammary fluid samples for evaluating breast diseases, including cancer
10/14/2009EP1259827B1 Biosynthetic carbohydrate-deficient transferrin references
10/14/2009EP1238115B1 Process for labeling a ribonucleic acid, and labeled rna fragments which are obtained thereby
10/14/2009EP1180686B1 Remedies for kidney diseases and method for screening the same
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009EP1144447B1 Tuberculosis diagnostic test
10/14/2009EP1108066B1 Reaction chambers coated with defined concentrations of nucleic acids, method for the production and use thereof
10/14/2009EP1007740B1 Method for characterizing disseminated and micrometastasized cancer cells
10/14/2009EP1005481B1 Methods for the production of aslv reverse transcriptases composed of multiple subunits
10/14/2009CN201327488Y Digital solar energy sperm quality analyzer
10/14/2009CN101558310A Method for stabilizing a-thrombin in thrombin-containing solution
10/14/2009CN101558308A Methods of treating, diagnosing or detecting cancer
10/14/2009CN101558306A Enzyme detection techniques
10/14/2009CN101558296A Method for measuring 1,5-anhydroglucitol in whole blood, and sensor chip and measurement kit to be used in the method
10/14/2009CN101558169A Treatment of pigs with PCV2 antigen
10/14/2009CN101558168A Detection of bacterium by utilizing DnaJ gene and use thereof
10/14/2009CN101558167A Detection of analytes and nucleic acids
10/14/2009CN101558155A A method and an apparatus for determining nucleotide sequence, and a computer program product to be executed by the apparatus
10/14/2009CN101557825A Proteolysis resistant antibody preparations
10/14/2009CN101556261A Method for detecting microorganism isoelectric point by adopting microtubule isoelectric focusing and cutting-blowout culture
10/14/2009CN101556249A Device for acquiring and processing signal of toxicity detector by bioluminescent method
10/14/2009CN101556243A Biosensor
10/14/2009CN101556242A Method for discriminating microorganism by utilizing Fourier infrared spectrum
10/14/2009CN101556227A Method for transiting cells through electrostatic adherence
10/14/2009CN101555529A Loop-mediated isothermal amplification technology-based Listeria monocytogenes rapid diagnostic kit and testing method thereof
10/14/2009CN101555528A Method for testing chromosome 22q11.2 microdeletion and microduplication
10/14/2009CN101555527A Kit used for detecting saccharomyces cerevisiae in intestinal tract by fluorescence quantitative PCR method
10/14/2009CN101555526A Kit used for detecting candida paropsilosis in intestinal tract by fluorescence quantitative PCR method
10/14/2009CN101555525A Kit used for detecting candida tropicalis in intestinal tract by fluorescence quantitative PCR method
10/14/2009CN101555524A Kit used for detecting candida glabrata in intestinal tract by fluorescence quantitative PCR method
10/14/2009CN101555523A Kit used for detecting candida krusei in intestinal tract by fluorescence quantitative PCR method
10/14/2009CN101555522A Kit used for detecting candida albicans in intestinal tract by fluorescence quantitative PCR method
10/14/2009CN101555521A Pair of Q-type bemisa babaci specificity SCAR primers, fast PCR detection method and kit
10/14/2009CN101555520A Has-mir-122 kit for early prediction of hepatocirrhosis developed from chronic hepatitis B and detection method thereof
10/14/2009CN101555519A Gene chip and application thereof
10/14/2009CN101555518A Micro ribonucleic acid and application thereof
10/14/2009CN101555517A Mycoplasma pneumoniae rapid identification and cultivation susceptibility test kit and test method
10/14/2009CN101555516A Candida albicans rapid identification and cultivation susceptibility test kit and test method
10/14/2009CN101555515A Diatom characteristic description and classification method based on contour drawing
10/14/2009CN101555514A Vibrio mimicus chromogenic culture medium
10/14/2009CN101555513A Production method of petroleum hydrocarbon oxidizing bacteria test bottles
10/14/2009CN101555481A Heat stable mutants of starch biosynthesis enzymes
10/14/2009CN101555479A Moss expressing promoting regions
10/14/2009CN101555476A Small interfering RNA, screening method and application in preparing medicament for treating neuropathic pains
10/14/2009CN101555474A Directional gene recombination kit based on screening after connection
10/14/2009CN101555468A Viral variants with altered susceptibility to nucleoside analogs and uses thereof
10/14/2009CN101555461A Bacterial strain LT3 producing alkalescence cellulase and breeding method and initial optimization of cellulase production conditions thereof
10/14/2009CN101555457A Genitourinary tract mycoplasma culture medium and detect method thereof
10/14/2009CN101555452A DNA analysis apparatus
10/14/2009CN100549693C Bioassary method for identifying insect-resistance performance of transgenic insect-resistance plant
10/14/2009CN100549679C Method for shortening analysing-time of end-point type reaction distribution diagram
10/14/2009CN100549183C Enzymatic diagnostic test for SARS and other viral diseases
10/14/2009CN100549173C PH gene with specific mononucleotide polymorphism, and its detecting method and use
10/14/2009CN100549172C Compositions and methods for prognosis and therapy of liver cancer
10/14/2009CN100549171C Polynucleotide for target gene
10/14/2009CN100549167C Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion
10/14/2009CN100549165C Calcineurin of clonorchis sinensis, its coding nucleic acid and application
10/14/2009CN100549009C Composition for detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone and method thereof
10/14/2009CA2656577A1 Method for evaluation of a cancer
10/13/2009USRE40937 endometrial bleeding associated factor (ebaf) gene for diagnosis of mucinous adenocarcinoma of the colon, or ovaries, or an adenocarcinoma of the testis; genetic probe
10/13/2009US7601885 Transgenic plant comprising a cassava vein mosaic virus promoter and a heterologous nucleic acid sequence
10/13/2009US7601851 Compounds and methods for fluorescent labeling
10/13/2009US7601845 Optically detectable organophosphonates
10/13/2009US7601831 Methods, kits and assay system for detecting drug-resistant mycobacterium tuberculosis
10/13/2009US7601829 for use in designing and/or identifying modulators of insect behavior; biolgical pest control
10/13/2009US7601828 Marker for susceptibility to micropenis, cryptorchidism, or hyposopadias; sexual differentiation disorders
10/13/2009US7601826 Genes and polypeptides relating to human pancreatic cancers
10/13/2009US7601822 Molecular identification of bacteria of genus Streptococcus and related genera
10/13/2009US7601821 Encoding and decoding reactions for determining target molecules
10/13/2009US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601806 isolated polypeptide encoded by an isolated nucleic acid molecule as antitumor biodrugs; modulation of chemokine, cytokine expression
10/13/2009US7601805 Photoprotein with improved bioluminescence
10/13/2009US7601804 immunogens for treating cattle diseases; biodrugs for veterinary medicine
10/13/2009US7601703 Complexing the target cell with therapeutic agent; antiproliferative agent
10/13/2009US7601700 Modified antisense oligonucleotide; antitumor and anticancer agents
10/13/2009US7601699 Treating cells and/or nuclear transfer units and/or stem cells in culture with compounds resulting in a globally hypomethylated genome and a restoration of cell differentiation and/or developmental potential, or potentiality; decreasing S-adenosylmethione-to-S-adenosylhomocysteine ratio
10/13/2009US7601690 Cross-linked glycopeptide-cephalosporin antibiotics
10/13/2009US7601687 Drug screening for non-insulin dependent diabetes mellitus, beta cell dysfunction and peripheral insulin resistance
10/13/2009US7601684 Test strips; medical diagnosis
10/13/2009US7601533 Reverse two-hybrid systems
10/13/2009US7601532 Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma
10/13/2009US7601521 Detection of nucleic acid mutation associated with cancer by analysis of saliva
10/13/2009US7601520 Using long, short and shared primers to replicate lean muscle mass-enhancing and lean muscle mass-suppressing alleles; predicting meat quality of swine
10/13/2009US7601512 Monitoring efficiency of fungicide in preventing plant fungal infections; disease resistant plants
10/13/2009US7601511 Biotinylation of compounds such as peptides and peptidomimetics facilitates illicit transport of the compounds into Gram negative bacteria; screening for antibiotics, or in drug delivery of antibiotics
10/13/2009US7601510 Development and use of fluorescent probes of unbound analytes
10/13/2009US7601508 Ecdysone receptor polypeptide from the homopteran whitefly (Bamecia argentifoli, BaEcR) use screening for monoclonal antibodies; biological insecticides
10/13/2009US7601505 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
10/13/2009US7601503 sequence-selective nucleic acid detection; polythiophenes containing pendant quaternary ammonium groups that are thermostable and autoclavable; use in DNA or RNA electrochemical or optical detection, or purification; diagnosis of infections or disease
10/13/2009US7601502 vaccination with a live equine influenza vaccine (prime) is followed by vaccination with an inactivated influenza vaccine (boost), wherein the two shots are given no longer than 8 weeks apart; horses
10/13/2009US7601501 screening for agents that promote osteogenesis; use treating bone disorders, promote differentiation path of mesenchymal stem cells into osteoblasts for tissue engineering
10/13/2009US7601500 vaccination with a live viral vaccine (prime) is followed by vaccination with an inactivated vaccine (boost) for the same virus, wherein the two shots are given no longer than 8 weeks apart; horses; equine herpes virus (EHV)
10/13/2009US7601499 Paired end sequencing
10/13/2009US7601498 Use of bridged nucleic acid fluorescent dyes, such as phenanthridinium dyes, cyanine dyes, or acridinium dyes each having an ammonium group and anion; bridging group can be -CH2-CONH-(CH2-CH2-O)x-(CH2)2-NHCO-CH2- ; low background fluorescence in the absence of nucleic acids; noncarcinogenic, stability
10/13/2009US7601497 increased rapidity and sensitivity, also highly specific and capable of discriminating between multiple highly homologous nucleic acid target sequences; multiplex analysis; use for diagnosis of diseases, detection of microorganisms, detecting genetic disorders; involves formation of DNA:RNA hybrids
10/13/2009US7601496 Exonucleases; solid phase synthesis
10/13/2009US7601495 MicroRNA; peptide nucleic acids; locked nucleic acids
10/13/2009US7601494 Method of screening candidate compounds for susceptibility to biliary excretion